TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06272591

Intervention type: OTHER
Intervention: Preliminary search in the patient's file
Description: Details of the information previously sought in the patient's file :~age profession gender/parity physiological or pathological pregnancy indication for induction of labour gestational age at time of induction

Intervention type: OTHER
Intervention: A posteriori research in the patient's file
Description: Data on maternal and foetal morbidity and mortality following childbirth will be collected.

Intervention type: OTHER
Intervention: First questionnaire : choice of induction method reason for choice
Description: Given on arrival at the maternity unit to begin induction.

Intervention type: OTHER
Intervention: Second questionnaire : experience of induction
Description: Given post-partum in the maternity unit.
Study: NCT05714618

Intervention type: DIAGNOSTIC_TEST
Intervention: B Natriuretic Peptide
Description: Measurement of B Natriuretic Peptide on patients' blood samples at 10 and 60+/-15 days.

Intervention type: DIAGNOSTIC_TEST
Intervention: B Natriuretic Peptide
Description: Measurement of B Natriuretic Peptide on patients' blood samples at 10 and 60+/-15 days.
Study: NCT05829109

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplant (FMT)
Description: The intervention consists of the following steps:~* Step 1: Vancomycin 125 mg orally every 6 hours and metronidazole 250 mg orally every 6 hours for 5 days.~* Step 2: Bowel preparation with 10 ounces of magnesium citrate.~* Step 3: Two FMT doses will be administered via enema one week apart using stool from donors with a durably healthy pouch.
Study: NCT06372340

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Personalized pelvic floor rehabilitation program generated by the intelligent diagnosis and treatment system.
Description: Utilizing machine learning to process and analyze vast amounts of previously collected data, the investigators will establish an intelligent system that can generate personalized pelvic floor exercise prescription by matching factors such as general clinical information and pelvic floor muscle strength data. The experimental group will receive tailored program, including pelvic floor muscle training with diverse intensity and frequency, electrical stimulation, magnetic stimulation, biofeedback and other treatments. The results will ultimately be compared with those taking standardized pelvic floor muscle training only.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard pelvic floor muscle training(PFMT) program
Description: Participants will be given handbooks with detailed training program: the basic regimen consists of 3 sets of 8 to 12 contractions sustained for 8 to 10 sec each, performed 3 times a day. Patients should try to do this every day and continue for at least 15 to 20 weeks.
Study: NCT04171674

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment with high-dose ceftobiprole (500mg loading dose followed by 2.5g under continuos infusion).
Description: High-dose ceftobiprole (500mg loading dose) will be administered to patients for 30 minutes followed by 2.5g under continuous infusion for 24 hours.
Study: NCT06412094

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard care
Description: Recommendation of standard treatment plan, according to the clinical severity of the AD, and. are instruction to contact the doctor via messenger for any questions related to treatment recommendations.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Recommendation of standard treatment plan, according to the clinical severity of the AD, and. are instruction to contact the doctor via messenger for any questions related to treatment recommendations.
Study: NCT05714618

Intervention type: DIAGNOSTIC_TEST
Intervention: Systemic inflammatory markers
Description: Measurement of a panel of 92 systemic inflammatory markers on patients' blood samples at 10 and 60+/-15 days.

Intervention type: DIAGNOSTIC_TEST
Intervention: Systemic inflammatory markers
Description: Measurement of a panel of 92 systemic inflammatory markers on patients' blood samples at 10 and 60+/-15 days.
Study: NCT05392790

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive resisted exercise training
Description: Progressive resisted exercises will be started with the 8 maximum repetition test (8 RM) performed at progressive intensities. The subject will perform the 8 RM test at the beginning and the end of each cycle over the two-month training period. Each training session lasts sixty minutes and will be performed three times per week on alternate days.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive resisted exercise training
Description: Progressive resisted exercises will be started with the 8 maximum repetition test (8 RM) performed at progressive intensities. The subject will perform the 8 RM test at the beginning and the end of each cycle over the two-month training period. Each training session lasts sixty minutes and will be performed three times per week on alternate days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium and Vit D
Description: Traditional medical treatment in the form of Calcium, Vit D and Bi phosphnate.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium and Vit D
Description: Traditional medical treatment in the form of Calcium, Vit D and Bi phosphnate.

Intervention type: DRUG
Group type: OTHER
Intervention: Calcium and Vit D
Description: Traditional medical treatment in the form of Calcium, Vit D and Bi phosphnate.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium and Vit D
Description: Traditional medical treatment in the form of Calcium, Vit D and Bi phosphnate.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercises
Description: Aerobic exercises will be applied at 70 - 80% of their maximum heart rate. Trained health professionals supervised the exercise program. Each exercise session will begin with a 5-10-minute warm-up, will be followed by 20 -30 minutes of aerobic activity, and will be concluded with a 5-10-minute cool-down period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercises
Description: Aerobic exercises will be applied at 70 - 80% of their maximum heart rate. Trained health professionals supervised the exercise program. Each exercise session will begin with a 5-10-minute warm-up, will be followed by 20 -30 minutes of aerobic activity, and will be concluded with a 5-10-minute cool-down period.
Study: NCT05470543

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse-led supportive care
Description: Nurse-led supportive care was given to primary caregivers of women with breast cancer. Nurse-led supportive care was applied to primary caregivers for eight weeks in the form of face-to-face clinic interviews. It took an average of 30 minutes to interview with primary caregivers at the clinic.
Study: NCT06428071

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard physical therapy
Description: All Patients in the three groups will receive supervised systematic exercise therapy that was performed effectively in previous work. This program consisted of lower limb static, dynamic, and flexibility exer¬cises that targeted the quadriceps, hamstrings, and gluteus muscles; and core strength training for 20 minutes per day. This program will be applied 3 times per week for 6 weeks to all the participants

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard physical therapy
Description: All Patients in the three groups will receive supervised systematic exercise therapy that was performed effectively in previous work. This program consisted of lower limb static, dynamic, and flexibility exer¬cises that targeted the quadriceps, hamstrings, and gluteus muscles; and core strength training for 20 minutes per day. This program will be applied 3 times per week for 6 weeks to all the participants

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard physical therapy
Description: All Patients in the three groups will receive supervised systematic exercise therapy that was performed effectively in previous work. This program consisted of lower limb static, dynamic, and flexibility exer¬cises that targeted the quadriceps, hamstrings, and gluteus muscles; and core strength training for 20 minutes per day. This program will be applied 3 times per week for 6 weeks to all the participants

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: knee Decompression
Description: continuous mechanical decompression using 20% of the body weight as a traction force for 15 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: knee Decompression
Description: continuous mechanical decompression using 20% of the body weight as a traction force for 15 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hot pack
Description: hot pack over the treated knee joint will be applied for 20 minutes. this application will be performed while the patient is receiving the decompression session
Study: NCT05056220

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Human albumin
Description: 20% Human Albumin infusions (every 10th day +/- 4 days) with dosing according to the participants bodyweight (1.5 grams of albumin per kg bodyweight with a maximum of 100 grams)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Human albumin
Description: 20% Human Albumin infusions (every 10th day +/- 4 days) with dosing according to the participants bodyweight (1.5 grams of albumin per kg bodyweight with a maximum of 100 grams)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sodium chloride
Description: 0.9% NaCl infusions (every 10th day +/- 4 days) with dosing according to the corresponding volume used of 20% Human Albumin (1.5 grams of albumin per kg bodyweight with a maximum of 100 grams)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sodium chloride
Description: 0.9% NaCl infusions (every 10th day +/- 4 days) with dosing according to the corresponding volume used of 20% Human Albumin (1.5 grams of albumin per kg bodyweight with a maximum of 100 grams)
Study: NCT05684796

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anticoagulation
Description: Anticoagulation with unfractionated heparin (UFH) or low molecular weight heparin (LMWH)

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: mechanical aspiration thrombectomy
Description: Mechanical aspiration thrombectomy with the Indigo Aspiration System.
Study: NCT06339242

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: After completion of all screening activities, eligible patients were confirmed to enter the study. All patients will receive study treatment, Furmonertinib tablets 160mg, oral, once daily, lateral ventricular chemotherapy with Ommaya capsule technique until disease progression, intolerable toxicity, death, withdrawal of informed consent.
Study: NCT05340387

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance Resistance Aerobic Cognitive exercises (BRACE)
Description: Study will be conducted after the approval of Ethical review board. The BRACE exercise training would be perform in 4 times a week for 12 weeks, lasting approximately 40-50 minutes each time. Week 1-3 : Balance: Romberg, tandom standing, single leg stance Resistance: chair rise Aerobic exercises: 6mint walk Cognitive: count reverse from 50 Week 4-6: Balance: Sit to stand, functional reach, Tug Test Resistance: stair climbing Aerobic Exercises: Marching in space Cognitive: Remember 5 words, spell backward, remember 5 animals Week 7-9: Balance: Perturbation, throwing a ball, kicking a ball Resistance: Floor transfer, squatting Aerobic Exercises: Cycling Cognitive: Count even number from 1-50, calculation, addition, subtraction, multiplication division Week 10-12: Balance: Combination of All Resistance: Combination of All Aerobic Exercises: 6 minutes' walk test, marching steps, cycling Cognitive: Combination of all

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Otago's Protocol
Description: Study will be conducted after the approval of Ethical review board. The Otago's exercise training would be perform in 4 times a week for 12 weeks, lasting approximately 40-50 minutes each time. WEEK 1-3: Warm up: March, head movement, neck movement, back extension, trunk movement, ankle movements Strength: Front knee strengthening, Back knee strengthening, Side hip strengthening, Calf raises, Toe raises (10 repetitions each) Balance: Knee bends, Backwards walking, Walking and turning around, Sideways walking, Tandem stance (heel toe stand), Tandem walk (heel toe walk), One leg stand, Heel walking, Toe walk, Heel toe walking backwards, Sit to stand, Stair walking. (10 repetitions each) Flexibility: calf stretch, back of thigh stretch Hold for 10 to 15 seconds and repeat on other leg.~Walk: 5 or 10 minutes' walk~This protocol will be followed for 12 weeks with increased repetitions after every 3 week.
Study: NCT05258214

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Bent Leg Raise
Description: Mulligan's bent leg raise, as well as the extreme Straight Leg Raise, can be used to relieve Low Back Pain. It can be used to treat leg discomfort that is above the knee. Bent Leg Raise methods are used where there is a restricted range of motion in the hip flexion joint, as well as low back pressure with or without referred leg pain.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Traction Straight Leg Raise
Description: Mulligan traction leg raise exercises are a non-invasive treatment that has been shown to help people with low back pain and reduced hip flexion range. Conservative sciatica therapy focuses on pain relief, but increasing Straight Leg Raise range will help restore normal mobility and reduce the severity of low back disability.
Study: NCT06412094

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard care
Description: Recommendation of standard treatment plan, according to the clinical severity of the AD, and. are instruction to contact the doctor via messenger for any questions related to treatment recommendations.
Study: NCT05586529

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Description: Cholecalciferol is vitamin D derivative and as our population already vit D deficient so post-operative hypocalcemia can be prevented.
Study: NCT06138301

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Description: CBT is a psychotherapeutic intervention that focuses on challenging and changing cognitive distortions (such as thoughts, beliefs, and attitudes) and their associated behaviours to improve emotional regulation and develop personal coping strategies that target solving current problems. In this study, patients with SI will undergo 8 sessions of CBT (45 min, once a week), remotely. Techniques and strategies of the intervention will be based on a short telepsychotherapy protocol previously published by our group (Biagianti et. al., 2021). Instead, the content of each session will be adapted to the psychopathology associated with social isolation and the age of the subject. The psychotherapeutic sessions of the patients will be audio-recorded in order to conduct retrospective analyzes of the patient's speech.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Description: CBT is a psychotherapeutic intervention that focuses on challenging and changing cognitive distortions (such as thoughts, beliefs, and attitudes) and their associated behaviours to improve emotional regulation and develop personal coping strategies that target solving current problems. In this study, patients with SI will undergo 8 sessions of CBT (45 min, once a week), remotely. Techniques and strategies of the intervention will be based on a short telepsychotherapy protocol previously published by our group (Biagianti et. al., 2021). Instead, the content of each session will be adapted to the psychopathology associated with social isolation and the age of the subject. The psychotherapeutic sessions of the patients will be audio-recorded in order to conduct retrospective analyzes of the patient's speech.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR)
Description: The cognitive training will consist of 10 hours (30 minutes/session) of computer-based exercises focusing on working memory, attention, executive functions and social cognition, which will be performed online using BrainHQ software. This software allows for the customization of the training based on the specific characteristics of each subject. For example, it allows automatic adjustment of the difficulty of the exercises, trial by trial and session by session, in order to guarantee an adequate level of attention and motivation for the entire duration of the training and therefore favor optimal learning rates.
Study: NCT06412094

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Access to the AtopicApp mobile application
Description: Access to the AtopicApp mobile application with 1 day after enrollment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Access to the AtopicApp mobile application
Description: Access to the AtopicApp mobile application with 1 day after enrollment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual oversight through the AtopicApp
Description: Notification of doctor's virtual oversight through the AtopicApp mobile application.
Study: NCT06071052

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TACE and HAIC Combined With Regorafenib
Description: TACE and HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer who failed the second line treatment regimens
Study: NCT05258214

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neural Mobilization
Description: These techniques are designed to mobilize a nerve with as little pressure down, resulting in a larger longitudinal excursion than techniques that actually lengthen the nerve bed, such as tensioning procedures.
Study: NCT05018156

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Default Genetics Referral Process
Description: Patients and their oncology providers will be notified of their eligibility for a cancer genetics referral, with an option to opt out if they are not interested in proceeding. Everyone else will be automatically referred to their local hospital's cancer genetics program for contact and scheduling. Standard genetic counseling, testing, and results disclosure will take place, including usual methods of payment and insurance coverage for testing.
Study: NCT05461755

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Fractional radiofrequency and topical Tretinoin
Description: Treatment of striae with fractional radiofrequency and topical tretinoin in combination

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical Tretinoin
Description: Treatment of striae with topical tretinoin alone

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fractional radiofrequency
Description: Treatment of striae with fractional radiofrequency alone
Study: NCT04217330

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Choice of home-based or centre-based pulmonary rehabilitation
Description: Participants will be offered the choice of HomeBase, a home-based pulmonary rehabilitation program, or the traditional centre-based pulmonary rehabilitation program.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Centre-based pulmonary rehabilitation
Description: Participants will be offered a traditional centre-based pulmonary rehabilitation program
Study: NCT06379516

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moisturising Cream (5%)
Description: This intervention is a moisturiging cream of concentration 5% for topical application to the respective test sites.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moisturising Cream (10%)
Description: This intervention is a moisturiging cream of concentration 10% for topical application to the respective test sites.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Coconut Oil
Description: This intervention is a 100% pure coconut oil product (Parachute Pure Coconut Oil) for topical application to the respective test sites.
Study: NCT06117670

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: posterior colporrhaphy using gamma-irradiated amniotic membrane as a graft
Description: Posterior colporrhaphy with application of the gamma-irradiated amniotic membrane graft will be done
Study: NCT05254275

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ozoral Pro and Ozoral gel administration
Description: Peri-implant mucositis sites will receive in-office Ozoral Pro administration after non-surgical therapy. Patients will use Ozoral Gel for the domiciliary administration once a day for 14 days after the visits (no rinsing and eating for 30 minutes after gel application).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Curasept chlorhexidine gel 1%
Description: Peri-implant mucositis sites will receive in-office Curasept chlorhexidine gel 1% administration after non-surgical therapy. Patients will use chlorhexidine gel 1% for the domiciliary application once a day for 14 days after the visits (no rinsing and eating for 30 minutes after gel application).
Study: NCT06017921

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Eszopiclone 3 mg
Description: Patients starting CPAP treatment will be randomized to either Eszopiclone or Placebo arm

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients starting CPAP treatment will be randomized to either Eszopiclone or Placebo arm
Study: NCT06475209

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab combined with Apatinib
Description: Each treatment cycle spans 3 weeks. Sequential medication administration begins on the first day of each cycle: Atezolizumab is administered at a dosage of 1200mg on day 1, every 3 weeks, while Apatinib is given orally at a dosage of 250mg daily from day 1 to day 14, every 3 weeks, with a one-week hiatus following two weeks of continuous intake. Administration timing allows for a window of ±5 days. Subjects are required to undergo comprehensive assessments, including vital signs monitoring, anthropometric measurements, physical examinations, laboratory analyses, and performance status evaluations, to assess treatment tolerability for continuation.
Study: NCT06399510

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sterofundin fluid therapy
Description: Sterofundin is known as balanced solution which has similar electrolytes content as per human plasma.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sterofundin fluid therapy
Description: Sterofundin is known as balanced solution which has similar electrolytes content as per human plasma.